KLK3 and prostate carcinoma: Bergengren et al. revealed that using PSA testing resulted in a 15% decrease in prostate cancer deaths from 1996 to 2016 (11) and it is crucial to clarify the factors that affect PSA in order to ensure quality screening and prevent missed diagnoses.